Standardization of polyherbal Siddha formulation aavarai poovarisi chooranam – anti-diabetic drug by pharmaceutical analytical techniques

Authors

  • B.Bharathi PG Scholar, Post Graduate Department of Gunapadam (Pharmacology), Government Siddha Medical College, Chennai, Tamilnadu, India
  • M.Sangeetha PG Scholar, Post Graduate Department of Gunapadam (Pharmacology), Government Siddha Medical College, Chennai, Tamilnadu, India
  • M.D.Saravanadevi Professor, Head of the department, Post Graduate Department of Gunapadam (Pharmacology), Government Siddha Medical College, Chennai , Tamilnadu, India
  • V.Velpandian Professor, Post Graduate Department of Gunapadam (Pharmacology), Government Siddha Medical College, Chennai, Tamilnadu, India

DOI:

https://doi.org/10.47957/ijpda.v10i2.499

Keywords:

Aavarai Poovarisi Chooranam, Polyherbal formulation, Phyto-chemical, Physico-chemical

Abstract

Aavarai Poovarisi Chooranam is a Siddha poly herbal formulation plays an important role in treating Diabetes alone or in combination. Chooranam is applied to the powder made by a single or a mixture of herbal ingredients. The drugs required for making Aavarai Poovarisi Chooranam were collected and authenticated by experts and prepared as per siddha literature. It was then subjected to preliminary phyto-chemical analysis, physico-chemical, high performance thin layer chromatographic finger printing was done through CAMAG software, biochemical analysis, heavy metal analysis, pesticide residue, aflatoxin and microbial load analysis prior to toxicology and pharmacology testing. The obtained results were within normal limits in this study, which is briefly described in this paper.

Downloads

Download data is not yet available.

References

Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019 Nov 1; 157:107843.

Gupta SK, Singh Z, Purty AJ, et al. Diabetes prevalence and its risk factors in rural area of Tamil Nadu. Indian J Community Med. 2010 Jul; 35(3):396-399

Siddha Materia Medica (Medicinal Plants Division) Part 1. 2nd ed. Chennai: Directorate of Indian Medicine and Homeopathy Department; 84-86, (2002).

Hakkim P.M A. Mega Nivarana Bodini Ennum Neerizhivu Maruthuvam. 1st ed. Thamarai Noolagam, Chennai: S.P Ramachandran; 164-165, (1998).

Aanaivaari A. Sarakku Suthi Sei Muraigal. Department of Indian Medicine and Homeopathy, Chennai-106;2008.P 6-13.

India Pharmacopeia I Volume I, Government of India, Ministry of Health and Family welfare, Indian Pharmacopeia commission, 2014.

Lohar DR. Pharmacopoeial laboratory for Indian medicine. Department of Ayurvedha, Yoga and Naturopathy, Siddha, Unani and Homoeopathy (AYUSH), Ministry of Health and Family Welfare. New Delhi. 2011.

Hiroi T, Shibayama M. Measurement of particle size distribution in turbid solutions by dynamic light scattering microscopy. JoVE (Journal of Visualized Experiments). 2017 Jan 9(119):e54885.

Brain KR, Turner TD. The Practical Evaluation of Phytopharmaceuticals. Bristol: Wright Scientechnica; 1975:36-45

Komsta L, Waksmundzka-Hajnos M, Sherma J, editors. Thin layer chromatography in drug analysis. CRC Press; 2013 Dec 20.

Wagner H, Bladt S. Plant drug analysis: a thin layer chromatography atlas. Springer Science & Business Media; 1996.

Anonymous, 1998, Bio chemical Standards of Unani formulations, Part3, CCRUM, New Delhi, P.no.58-60.

Protocol for testing Ayurvedic, Siddha &Unani Medicines. Government of India, Department of AYUSH, Pharmacopoeial laboratory for Indian Medicines; P; 69-73

D.r. lohar, Protocol for testing Ayurvedic, Siddha & Unani Medicines, Ministry of Health & Family Welfare, Pharmacopoeial Laboratory for Indian medicines Ghaziabad, 29 May 2014; 77.

Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Eleventh Edition. CLSI document M02-A11. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.

WHO G. WHO guidelines for assessing quality of herbal medicines with reference to contaminants and residues. 2007

Lohar DR.Protocol for Testing. Ayurvedic, Siddha, Unani Medicines, Government of India, Department of AYUSH, Ministry of Health & Family Welfare, Pharmacopoeial Laboratory for Indian Medicines, Ghaziabad, 30th March. 2007.

CASTRO LD, Vargas EA. Determining aflatoxins B1, B2, G1 and G2 in maize using florisil clean up with thin layer chromatography and visual and densitometric quantification. Food Science and Technology. 2001 Jan;21(1):115-22.

Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. International Scholarly Research Notices. 2012;2012.

Kooti W, Farokhipour M, Asadzadeh Z, Ashtary-Larky D, Asadi-Samani M. The role of medicinal plants in the treatment of diabetes: a systematic review. Electronic physician. 2016 Jan;8(1):1832.

D'souza JJ, D'souza PP, Fazal F, Kumar A, Bhat HP, Baliga MS. Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action. Food & function. 2014; 5(4):635-44.

Variya BC, Bakrania AK, Patel SS. Antidiabetic potential of Gallic acid from Emblica officinalis: Improved glucose transporters and insulin sensitivity through PPAR-? and Akt signaling. Phytomedicine. 2020 Jul 15; 73:152906.

Vlassara H, Uribarri J, Cai W, Goodman S, Pyzik R, Post J, Grosjean F, Woodward M, Striker GE. Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clinical Journal of the American Society of Nephrology. 2012 Jun 1;7(6):934-42.

Szabo C. Roles of hydrogen sulfide in the pathogenesis of diabetes mellitus and its complications. Antioxidants & redox signaling. 2012 Jul 1;17(1):68-80.

Ditzel J, Lervang HH. Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials. Diabetes, metabolic syndrome and obesity: targets and therapy. 2009; 2:173

Ranasinghe P, Pigera S, Galappatthy P, Katulanda P, Constantine GR. Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications. DARU Journal of Pharmaceutical Sciences. 2015 Dec;23(1):1-3.

Sahoo A, Pradhan B. Serum Magnesium Status among Type 2 Diabetes Mellitus and Its Chronic Complications.

Published

2022-07-07
Statistics
41 Views | 23 Downloads
Citatons

How to Cite

B, B., S. M, S. M.D, and V. V. “Standardization of Polyherbal Siddha Formulation Aavarai Poovarisi Chooranam – Anti-Diabetic Drug by Pharmaceutical Analytical Techniques”. International Journal of Pharmaceutics and Drug Analysis, vol. 10, no. 2, July 2022, pp. 09-17, doi:10.47957/ijpda.v10i2.499.

Issue

Section

Research Articles
Share |